Unknown

Dataset Information

0

NF-?B signaling is required for XBP1 (unspliced and spliced)-mediated effects on antiestrogen responsiveness and cell fate decisions in breast cancer.


ABSTRACT: Antiestrogen therapy induces the unfolded protein response (UPR) in estrogen receptor-positive (ER(+)) breast cancer. X-box binding protein 1 (XBP1), which exists in the transcriptionally inactive unspliced form [XBP1(U)] and the spliced active form [XBP1(S)], is a key UPR component mediating antiestrogen resistance. We now show a direct link between the XBP1 and NF-?B survival pathways in driving the cell fate decisions in response to antiestrogens in ER(+) breast cancer cells, both in vitro and in a xenograft mouse model. Using novel spliced and nonspliceable forms of XBP1, we show that XBP1(U) functions beyond being a dominant negative of XBP1(S). Both isoforms regulate NF-?B activity via ER?; XBP1(S) is more potent because it also directly regulates p65/RelA expression. These findings provide new insights into the fundamental signaling activities of spliced and unspliced XBP1 in breast cancer, establish NF-?B to be a mediator of these activities, and identify XBP1 and its splicing to be novel therapeutic targets.

SUBMITTER: Hu R 

PROVIDER: S-EPMC4272419 | biostudies-literature | 2015 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

NF-κB signaling is required for XBP1 (unspliced and spliced)-mediated effects on antiestrogen responsiveness and cell fate decisions in breast cancer.

Hu Rong R   Warri Anni A   Jin Lu L   Zwart Alan A   Riggins Rebecca B RB   Fang Hong-Bin HB   Clarke Robert R  

Molecular and cellular biology 20141103 2


Antiestrogen therapy induces the unfolded protein response (UPR) in estrogen receptor-positive (ER(+)) breast cancer. X-box binding protein 1 (XBP1), which exists in the transcriptionally inactive unspliced form [XBP1(U)] and the spliced active form [XBP1(S)], is a key UPR component mediating antiestrogen resistance. We now show a direct link between the XBP1 and NF-κB survival pathways in driving the cell fate decisions in response to antiestrogens in ER(+) breast cancer cells, both in vitro an  ...[more]

Similar Datasets

| S-EPMC6857227 | biostudies-literature
| S-EPMC5177917 | biostudies-literature
2016-12-21 | GSE78070 | GEO
| S-EPMC8552041 | biostudies-literature
| S-EPMC4015919 | biostudies-literature
| S-EPMC8313550 | biostudies-literature
| S-EPMC8627599 | biostudies-literature
| S-EPMC3993726 | biostudies-literature
| S-EPMC6652780 | biostudies-literature
| S-EPMC4073207 | biostudies-literature